Introduction of Typhoid Conjugate Vaccines in Africa and Asia.
Africa
Asia
TyVAC
typhoid
vaccine
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
15 02 2019
15 02 2019
Historique:
entrez:
16
2
2019
pubmed:
16
2
2019
medline:
30
1
2020
Statut:
ppublish
Résumé
Typhoid fever continues to be a major public health concern, particularly in many low- and middle-income countries. The current threats of increasing antimicrobial resistance, urbanization, and climate change elevate the urgency for better prevention and control efforts for typhoid fever. In 2017, the results of ground-breaking research on typhoid conjugate vaccines (TCVs), the World Health Organization prequalification of a TCV, and global policy and financing decisions have set the stage for the introduction of TCVs into routine immunization programs in endemic countries. Country-level decision-making and program planning are critical for local uptake and sustainability.
Identifiants
pubmed: 30767005
pii: 5320189
doi: 10.1093/cid/ciy878
pmc: PMC6376078
doi:
Substances chimiques
Typhoid-Paratyphoid Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S27-S30Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
Hum Vaccin. 2010 Dec;6(12):1021-4
pubmed: 21150269
BMJ Open. 2017 Jul 2;7(6):e016283
pubmed: 28674145
PLoS Negl Trop Dis. 2017 Feb 27;11(2):e0005376
pubmed: 28241011
Clin Infect Dis. 2018 Jun 18;67(1):18-24
pubmed: 29351594
Lancet. 2017 Dec 2;390(10111):2472-2480
pubmed: 28965718
PLoS Negl Trop Dis. 2015 Apr 24;9(4):e0003748
pubmed: 25909750
PLoS One. 2017 Jun 2;12(6):e0177773
pubmed: 28575074
Clin Infect Dis. 2015 Aug 1;61(3):393-402
pubmed: 25870324